MPS Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

-

-

0.03

-

-

Operating profit

-0.80

-0.95

-0.68

-4.13

-0.68

Interest

-

-

-

-

-

Gross profit

-0.71

-0.93

-0.42

-3.94

-0.66

EPS (Rs)

-0.43

-0.55

-0.07

-2.31

-0.61

Other income

0.09

0.02

0.26

0.20

0.02

Stock adjustment

-

-

-

-

-

Raw material

-

0.05

0.02

-

-

Power and fuel

-

-

-

-

-

Employee expenses

0.53

0.49

0.42

0.40

0.45

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

0.27

0.42

0.27

3.73

0.23

Provisions made

-

-

-

-

-

Depreciation

0.15

0.15

0.51

0.56

0.57

Taxation

-0.02

-0.02

-0.79

-0.08

-0.07

Net profit / loss

-0.83

-1.05

-0.14

-4.42

-1.17

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

19.11

19.11

19.11

19.11

19.11

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-

-

-2,086.42

-

-

GPM (%)

-

-

-144.15

-

-

NPM (%)

-

-

-48.73

-

-